Related Experiment Video

Updated: Apr 20, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.3K

Looking into a conceptual framework of ROS-miRNA-atrial fibrillation

Seahyoung Lee1, Eunhyun Choi2, Min-Ji Cha3

  • 1Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung-si, Gangwon-do 210-701, Korea. sam1017@ish.or.kr.

International Journal of Molecular Sciences
|November 29, 2014
PubMed

Insights

Reactive oxygen species (ROS) may influence atrial fibrillation (AF) development by regulating microRNAs (miRNAs). This review explores the potential ROS-miRNA-AF framework for novel AF therapies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Atrial fibrillation (AF) is a primary cause of cardiovascular morbidity and mortality.
  • MicroRNAs (miRNAs) are emerging biomolecules implicated in cardiac arrhythmogenesis.
  • Reactive oxygen species (ROS) are linked to both AF and miRNA regulation.

Purpose of the Study:

  • To explore the potential connections among AF, miRNAs, and ROS.
  • To understand the molecular interactions underlying arrhythmia development.
  • To identify novel therapeutic targets for AF.

Main Methods:

  • Systematic literature review.
  • Analysis of existing research on ROS, miRNAs, and AF.
  • Synthesis of molecular mechanisms linking these components.

Main Results:

  • Evidence suggests miRNAs associated with AF may be regulated by ROS.
  • A potential framework of ROS-miRNA-AF interactions in arrhythmia pathogenesis is proposed.
  • miRNAs may act as mediators, translating cellular stressors like ROS into AF.

Conclusions:

  • The proposed ROS-miRNA-AF framework offers a new perspective on AF pathogenesis.
  • Further experimental studies are needed to validate this framework.
  • Understanding these interactions could lead to innovative AF therapies.

More Related Videos

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

4.0K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.4K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
943
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K